Opens in a new tab
  1. Home
  2. /
  3. Sectors
  4. /
  5. Health research
Sector

From the clinical registry to a result a reviewer can verify

Survival, longitudinal data, predictive models and instrument validation: the statistical work that underpins a clinical study from start to finish.

Data from clinical practice are not necessarily collected to answer a research question. A registry can build up years of follow-up and still contain changes in criteria, loss to follow-up or events that do not lend themselves to a simple reading. A scale can produce a precise score and still fail to measure the construct of interest reliably. A predictive model can discriminate well and fall short exactly where it matters: in calibration, generalisation or clinical interpretation.

We work with clinical research groups, hospital departments and quality units. Knowledge of the care context and the clinical decision stay with the team that runs the study; our job is to turn the question into an analysis that respects how the data were produced, to estimate what the design allows to be estimated, and to quantify the uncertainty without hiding the limitations.

It is one of the areas where Azahar has the longest track record, with six published case studies and peer-reviewed research output on device survival, explainable predictive models and psychometric validation of clinical instruments.

We regularly work with

  • Hospital clinical research groups who want to take a question from the protocol to a methods and results section that can be reviewed and reproduced.

  • Departments and units with their own registries, built up over years, who need to know which questions that follow-up can really answer before choosing the model.

  • Teams who have developed, adapted or are using a questionnaire and need to show what it measures, how reliably and how its score should be interpreted.

  • Projects with small samples or difficult designs, where the point is not to force the usual analysis but to match the inference to the information that is actually available.

Services in this sector

Where we usually come into a clinical research project

In clinical research, the entry point depends less on the name of the method than on the problem the study poses. Sometimes the decision is how to measure before collecting anything; at other times it is understanding a follow-up, or modelling risk or trajectories with the data already available; and in other projects the question lies in comparing performance, costs or patient flows. If you would rather start from what you need to do than from your sector, each block leads to the full path for that need.

Frequently asked questions

What we are usually asked in this sector

We have a registry with years of follow-up. What can we get out of it?

It may hold a great deal of information, but the years accumulated do not on their own determine what can be concluded. First you need to know how events were defined, what happens when a patient stops appearing, whether the recording criteria changed and which variables were measured comparably throughout the period. From there, the decision is whether the question calls for survival analysis, competing risks, longitudinal models, transitions between states or another approach. The method comes after characterising the process that generated the data, because what each estimate really means depends on that process.

Our study has few patients. Is it worth analysing?

It can be, but a small sample means scaling back the ambition of the inference. No method can create information that the study does not contain. When there is sufficiently documented prior knowledge, a Bayesian approach can be useful for incorporating it explicitly and expressing uncertainty in directly interpretable terms; in other cases, the best decision may be to simplify the model, prioritise estimation over hypothesis testing or treat the work as exploratory. The choice depends on the question, the design and how much external support exists, not only on the number of patients.

We want to validate a scale we have developed. What does that involve?

It involves showing that the score the instrument produces can be interpreted as intended. Depending on the design and the stage of development, that may require studying its internal structure, consistency, stability over time and relationship with other measures it should converge with or diverge from. You also need to set how it is scored, how missing items are handled and which dimensions can be summarised without losing meaning. The result is not simply a Cronbach's alpha, but a documented justification of what the scale measures, how reliably and within what limits it can be used.

Shall we talk?

Tell us where your study stands and we'll give you a straight answer on how we can help.